ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GC34918-50mg |
|
1661020-92-3 |
MW-150 dihydrochloride dihydrate
|
0 | C24H29Cl2N5O2 | |
GC34918-10mg |
|
1661020-92-3 |
MW-150 dihydrochloride dihydrate
|
0 | C24H29Cl2N5O2 | |
GC34918-5mg |
|
1661020-92-3 |
MW-150 dihydrochloride dihydrate
|
0 | C24H29Cl2N5O2 | |
GC34914-10mg |
|
20559-16-4 |
LysoPC(14:0/0:0)
|
0 | C22H46NO7P | |
GC34914-5mg |
|
20559-16-4 |
LysoPC(14:0/0:0)
|
0 | C22H46NO7P | |
GC34912-50mg |
|
150566-71-5 |
Levamlodipine besylate
|
0 | C26H31ClN2O8S | |
GC34912-10mg |
|
150566-71-5 |
Levamlodipine besylate
|
0 | C26H31ClN2O8S | |
GC34912-10mM (in 1mL DMSO) |
|
150566-71-5 |
Levamlodipine besylate
|
0 | C26H31ClN2O8S | |
GC34910-10mg |
|
— |
Katacalcin TFA
|
0 | C99H155F3N34O38S2 | |
GC34910-5mg |
|
— |
Katacalcin TFA
|
0 | C99H155F3N34O38S2 | |
GC34910-1mg |
|
— |
Katacalcin TFA
|
0 | C99H155F3N34O38S2 | |
GC34910-500μg |
|
— |
Katacalcin TFA
|
0 | C99H155F3N34O38S2 | |
GC34909-100mg |
|
— |
JR-AB2-011
|
0 | C17H14Cl2FN3OS | |
GC34909-50mg |
|
— |
JR-AB2-011
|
0 | C17H14Cl2FN3OS | |
GC34909-25mg |
|
— |
JR-AB2-011
|
0 | C17H14Cl2FN3OS | |
GC34909-10mg |
|
— |
JR-AB2-011
|
0 | C17H14Cl2FN3OS | |
GC34909-5mg |
|
— |
JR-AB2-011
|
0 | C17H14Cl2FN3OS | |
GC34909-10mM (in 1mL DMSO) |
|
— |
JR-AB2-011
|
0 | C17H14Cl2FN3OS | |
GC34907-100mg |
|
200134-22-1 |
INH14
|
0 | C15H16N2O | |
GC34907-50mg |
|
200134-22-1 |
INH14
|
0 | C15H16N2O | |